Press Releases

SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s (GSK) belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma. Under the clinical trial collaboration agreement, GSK will sponsor and conduct an adaptive Phase...

Velabs Therapeutics GmbH, a leader in rapid screening of functional therapeutic antibodies, announced the closing of a €3 million Series B financing round to advance its functional antibody screening programme and to strengthen its own pipeline of preclinical functional...

AbbVie , a research-based global biopharmaceutical company announced that the U.S. FDA  has lifted the partial clinical hold placed on CANOVA (M13-494), a Phase 3 trial evaluating venetoclax (VENCLEXTA® OR VENCLYXTO®) for the investigational treatment of relapsed/refractory multiple myeloma....

Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the world’s health. Announced  its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution...

Pharmacosmos A/S announces publication of positive results from the FERWON-NEPHRO study and the pre-specified pooled safety analyses of the FERWON-NEPHRO and FERWON-IDA studies at the 56th ERA-EDTA congress in Budapest, Hungary. FERWON-NEPHRO is the second trial...

Quanticate, a leading global data-focused clinical research organisation(CRO), has announced plans to expand its presence in North America with the opening of a new office in Toronto. Quanticate will deliver statistical consultancy, programming, data management, pharmacovigilance,...

Anaqua’s ideaPoint, a leading provider of innovation management solutions, announced the launch of partnering software ideaPoint 5.1 along with Mobile Scout TM v2. The new release gives technology scouts and innovation managers additional tools to discover,...